| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 20 |
| 1 | BEVACIZUMAB | 15 |
| 2 | CARBOPLATIN | 13 |
| 3 | PEMBROLIZUMAB | 13 |
| 4 | CISPLATIN | 12 |
| 5 | PACLITAXEL | 10 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 10 |
| 7 | IPILIMUMAB | 9 |
| 8 | FLUOROURACIL | 7 |
| 9 | FLUOROURACIL CREAM, 0.5% | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORFIMER SODIUM | 1 | 0.0029 |
| 1 | ESTAZOLAM | 2 | 0.0010 |
| 2 | PENICILLIN G SODIUM | 1 | 0.0009 |
| 3 | ESOMEPRAZOLE SODIUM | 2 | 0.0008 |
| 4 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 5 | GLUTATHIONE | 1 | 0.0006 |
| 6 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 7 | THIOGUANINE | 1 | 0.0005 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 9 | SILVER SULFADIAZINE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 37 | 0.0004 |
| 1 | Vitamin K [EPC] | 3 | 0.0003 |
| 2 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |
| 4 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 5 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 25 | 0.0001 |
| 8 | Penem Antibacterial [EPC] | 3 | 0.0001 |
| 9 | Bile Acid [EPC] | 2 | 0.0001 |